At a glance
- Originator Pharmacia Corporation
- Class Antihyperlipidaemics
- Mechanism of Action Cholesterol ester transfer protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Atherosclerosis; Hypercholesterolaemia
Most Recent Events
- 20 Sep 2000 New profile
- 20 Sep 2000 Preclinical development for Atherosclerosis in USA (Unknown route)
- 20 Sep 2000 Preclinical development for Hypercholesterolaemia in USA (Unknown route)